MorphoSys ADR earnings, Revenue miss in Q3

  • Investing.com
MorphoSys ADR earnings, Revenue miss in Q3

Investing.com - MorphoSys ADR reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.

MorphoSys ADR announced earnings per share of €-0.9503 on revenue of €44.94M. Analysts polled by Investing.com anticipated EPS of €-0.8326 on revenue of €46.29M.

MorphoSys ADR shares are down 61.12% from the beginning of the year and are trading at €10.36 , down-from-52-week-high.They are under-performing the Nasdaq which is up 21.22% year to date.

MorphoSys ADR follows other major Healthcare sector earnings this month

MorphoSys ADR's report follows an earnings beat by J&J on Tuesday, October 19, 2021, who reported EPS of €2.6 on revenue of €23.34B, compared to forecasts EPS of €2.35 on revenue of €23.64B.

Pfizer had beat expectations on Tuesday, November 2, 2021 with third quarter EPS of €1.34 on revenue of €24.09B, compared to forecast for EPS of €1.08 on revenue of €22.58B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles